Possible Transfusion-Transmitted Babesia divergens-like/MO-1 Infection in an Arkansas Patient.

Abstract

A patient with asplenia and multiple red blood cell transfusions acquired babesiosis infection with Babesia divergens-like/MO-1 organisms and not Babesia microti, the common United States species. He had no known tick exposure. This is believed to be the first transfusion-transmitted case and the fifth documented case of B. divergens-like/MO-1 infection.

• Authors: Mary J Burgess, Eric R Rosenbaum, Bobbi S Pritt, Dirk T Haselow, Katie M Ferren, Bashar N Alzghoul, Juan Carlos Rico, Lynne M Sloan, Poornima Ramanan, Raghunandan Purushothaman, Robert W Bradsher
• Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 64 Issue 11 Pg. 1622-1625 (Jun 01 2017) ISSN: 1537-6591 [Electronic] United States
• PMID: 28329282 (Publication Type: Case Reports, Journal Article)
• Copyright: © The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].

Chemical References

• Clindamycin
• Quinine
• Doxycycline

Topics

• Aged, 80 and over
• Arkansas
• Babesia (isolation & purification)
• Babesiosis (drug therapy, parasitology, transmission)
• Blood Transfusion
• Clindamycin (administration & dosage, therapeutic use)
• Doxycycline (administration & dosage, therapeutic use)
• Fatal Outcome
• Humans
• Male
• Platelet Transfusion
• Quinine (administration & dosage, therapeutic use)
• United States